|
1
|
Granter SR, Badizadegan K and Fletcher CD:
Myofibromatosis in adults, glomangiopericytoma, and myopericytoma:
A spectrum of tumors showing perivascular myoid differentiation. Am
J Surg Pathol. 22:513–525. 1998.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fletcher CDM, Unni KK and Mertens F (eds):
World Health Organization Classification of Tumours Pathology and
Genetics of Tumours of Soft Tissue and Bone. International Agency
for Research on Cancer (IARC) Press, Lyon, 2002.
|
|
3
|
Dray MS, McCarthy SW, Palmer AA, Bonar SF,
Stalley PD, Marjoniemi V, Millar E and Scolyer RA: Myopericytoma: A
unifying term for a spectrum of tumours that show overlapping
features with myofibroma. A review of 14 cases. J Clin Pathol.
59:67–73. 2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Numata I, Nakagawa S, Hasegawa S and Aiba
S: A myopericytoma of the nose. Acta Derm Venereol. 90:192–193.
2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhao M, Williamson SR, Sun K, Zhu Y, Li C,
Xia W, Qi H, Wang L, Linos K and Cheng L: Benign perivascular myoid
cell tumor (myopericytoma) of the urinary tract: A report of 2
cases with an emphasis on differential diagnosis. Hum Pathol.
45:1115–1121. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mentzel T, Dei Tos AP, Sapi Z and Kutzner
H: Myopericytoma of skin and soft tissues: Clinicopathologic and
immunohistochemical study of 54 cases. Am J Surg Pathol.
30:104–113. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rousseau A, Kujas M, Van Effenterre R,
Bocht AL, Carpentier A, Leroy JP and Poirier J: Primary
intracranial myopericytoma: Report of three cases and review of the
literature. Neuropathol Appl Neurobiol. 31:641–648. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lau SK, Klein R, Jiang Z, Weiss LM and Chu
PG: Myopericytoma of the kidney. Hum Pathol. 41:1500–1504.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen Z and Liang W: Myopericytoma
occurrence in the liver and stomach space: Imaging performance. BMC
Cancer. 17(143)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mannan AASR, McGinty J and Theise N:
Myopericytoma of the Liver. Am J Clin Pathol. 146 (Suppl
1)(S246)2016.
|
|
11
|
Wu F, Sun J, Dong J, Wang X and Gao Q:
Management of multicentric myopericytoma in the maxillofacial
region: A case report. Case Rep Oncol. 6:350–355. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Prado-Calleros HM, Galarza-Lozano D,
Arrieta-Gómez JR, Pombo-Nava A, Parraguirre-Martínez S and
Gutiérrez CJ: Myopericytoma arising adjacent to the common carotid
artery: Case report and systematic review of deep located neck
myopericytomas. Head Neck. 38:E2479–E2482. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nagai T, Kamimura T, Itou K, Fujii M,
Tsukino H, Mukai S, Akiyama Y, Kataoka H and Kamoto T:
Myopericytoma in urinary bladder: A case report. J Med Case Rep.
11(46)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chu ZG, Yu JQ, Yang ZG, Zhu ZY and Yuan
HM: Myopericytoma involving the parotid gland as depicted on
multidetector CT. Korean J Radiol. 10:398–401. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cao JH, Xu JP, Li YC, Lai J and Li Q:
Pulmonary myopericytoma: A case report and review of the
literatures. Chin Med J (Engl). 122:755–757. 2009.PubMed/NCBI
|
|
16
|
Zhang Z, Yu D, Shi H and Xie D: Renal
myopericytoma: A case report with a literature review. Oncol Lett.
7:285–287. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
European Association for Study of Liver
and European Organisation for Research and Treatment of Cancer.
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. Eur J Cancer. 48:599–641. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Quinn SF and Benjamin GG: Hepatic
cavernous hemangiomas: Simple diagnostic sign with dynamic bolus
CT. Radiology. 182:545–548. 1992.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Valls C, Gumà A, Puig I, Sanchez A, Andía
E, Serrano T and Figueras J: Intrahepatic peripheral
cholangiocarcinoma: CT evaluation. Abdom Imaging. 25:490–496.
2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Albazaz R, Patel CN, Chowdhury FU and
Scarsbrook AF: Clinical impact of FDG PET-CT on management
decisions for patients with primary biliary tumours. Insights
Imaging. 4:691–700. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lee SW, Kim HJ, Park JH, Park D I, Cho YK,
Sohn CI, Jeon WK and Kim BI: Clinical usefulness of 18F-FDG PET-CT
for patients with gallbladder cancer and cholangiocarcinoma. J
Gastroenterol. 45:560–566. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Petrowsky H, Wildbrett P, Husarik DB, Hany
TF, Tam S, Jochum W and Clavien PA: Impact of integrated positron
emission tomography and computed tomography on staging and
management of gallbladder cancer and cholangiocarcinoma. J Hepatol.
45:43–50. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sica GT, Ji H and Ros PR: CT and MR
imaging of hepatic metastases. Am J Roentgenol. 174:691–698.
2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Galle PR, Forner A, Llovet JM, Mazzaferro
V, Piscaglia F, Raoul JL, Schirmacher P and Vilgrain V: EASL
Clinical Practice Guidelines: Management of hepatocellular
carcinoma. J Hepatol. 69:182–236. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Locker GY, Hamilton S, Harris J, Jessup
JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF and Bast RC Jr:
ASCO. ASCO 2006 update of recommendations for the use of tumor
markers in gastrointestinal cancer. J Clin Oncol. 24:5313–5327.
2006.PubMed/NCBI View Article : Google Scholar
|
